The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A real-time dashboard of clinical trials for COVID-19
Open accessAbstract
In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of clinical candidate interventions to treat COVID-19 are emerging at an unprecedented rate. As of April 21, 2020, well over 500 clinical trials have been registered at the various international and national clinical trial registry sites. Findings from randomised clinical trials that have been published as of April 21, 2020, have investigated the efficacy of lopinavir–ritonavir compared with standard of care,1 hydroxychloroquine compared with best supportive care,2 favipiravir compared with arbidol,3 and lopinavir–ritonavir compared with arbidol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chen, C., Zhang, Y., Huang, J., Yin, P., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., et al. (2020) · doi:10.1101/2020.03.17.20037432 · Cited by 852 · cited 1×
“Findings from randomised clinical trials that have been published as of April 21, 2020, have investigated the efficacy of lopinavir-ritonavir compared with standard of care, 1 hydroxychloroquine compared with best supportive care, 2 favipiravir compared with arbidol, 3 and lopinavir-ritonavir compared with arbidol.”
Method
Cited by
Digital technologies in the public-health response to COVID-19
Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., Rees, G., Emery, V. C., Stevens, M. M., Keegan, N., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1011-4 · Cited by 1,195
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00160-0 · Cited by 416
Abbas, J., Wang, D., Su, Z., & Ziapour, A. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s284313 · Cited by 365
LitCovid: an open database of COVID-19 literature
Chen, Q., Allot, A., & Lu, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa952 · Cited by 253
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., & Dong, Y. (2020) · Advanced Materials · doi:10.1002/adma.202004452 · Cited by 152
Metadata
- Authors
- Thorlund, K., Dron, L., Park, J., Hsu, G., Forrest, J. I., & Mills, E. J.
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 2
- Issue
- 6
- Pages
- e286-e287
- ISSN
- 2589-7500 (ISSN-L)
- OpenAlex
- W3017796721
- Cited by
- 227
- References
- 1
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A real-time dashboard of clinical trials for COVID-19. https://app.cochat.ai/papers/10.1016/s2589-7500(20)30086-8
- The paper
- Thorlund, K., Dron, L., Park, J., Hsu, G., Forrest, J. I., & Mills, E. J. (2020). A real-time dashboard of clinical trials for COVID-19. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(20)30086-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.